These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16683575)

  • 1. [Proteomics and its application in the research of prostatic carcinoma].
    Hou ZJ; Li YQ
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):358-61. PubMed ID: 16683575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of prostate cancer.
    Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
    Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of expression profiling and proteomics in prostate cancer.
    Masters JR
    Anticancer Res; 2007; 27(3A):1273-6. PubMed ID: 17593619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond prostate-specific antigen: alternate serum markers.
    Ramírez ML; Nelson EC; Evans CP
    Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S; Byrum S; Siegel ER; Suva LJ
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicobiochemical study of diagnostic value of the panel including 10 potential protein markers of prostatic cancer].
    Shishkin SS; Dzeranov NK; Totrov KI; Kazachenko AV; Kovaleva MA; Toropygin IIu
    Urologiia; 2009; (1):56-8. PubMed ID: 19432234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B; Ball G; Rees R
    Vaccine; 2007 Sep; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW; Cheng LL
    Expert Rev Proteomics; 2007 Jun; 4(3):389-400. PubMed ID: 17552923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More precise prostate cancer prediction.
    Health News; 2004 Jan; 10(1):2. PubMed ID: 15002372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics beyond proteomics: toward clinical applications.
    Plymoth A; Hainaut P
    Curr Opin Oncol; 2011 Jan; 23(1):77-82. PubMed ID: 21107258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical approaches to proteomic biomarkers within prostate cancer radiotherapy trials.
    Christensen E; Evans KR; Ménard C; Pintilie M; Bristow RG
    Cancer Metastasis Rev; 2008 Sep; 27(3):375-85. PubMed ID: 18427732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary markers for prostate cancer.
    Downes MR; Byrne JC; Pennington SR; Dunn MJ; Fitzpatrick JM; Watson RW
    BJU Int; 2007 Feb; 99(2):263-8. PubMed ID: 17092277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
    Ransohoff DF
    J Clin Epidemiol; 2007 Dec; 60(12):1205-19. PubMed ID: 17998073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
    Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
    Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
    Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel tumor marker discovery of gastrointestinal cancers using various proteomic approaches].
    Tomonaga T; Nomura F
    Rinsho Byori; 2007 Jan; 55(1):63-8. PubMed ID: 17319493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.